Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease Dementia

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

(2017) Joakim Hertze et al.   JOURNAL OF ALZHEIMERS DISEASE

Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design

(2017) Ineke A. van Rossum et al.   JOURNAL OF ALZHEIMERS DISEASE

Advances in Alzheimer’s Disease Drug Development

(2015) Michael S Rafii et al.   BMC Medicine

Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability

(2015) Anthony Fourier et al.   CLINICA CHIMICA ACTA

Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia

(2015) Kumar B. Rajan et al.   NEUROLOGY

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

(2014) Jessica B. Langbaum et al.   Alzheimers & Dementia

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score

(2014) Napatkamon Ayutyanont et al.   JOURNAL OF CLINICAL PSYCHIATRY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy

(2014) E. Coppi et al.   NEUROLOGICAL SCIENCES

Predicting decline in mild cognitive impairment: A prospective cognitive study.

(2014) Sylvie Belleville et al.   NEUROPSYCHOLOGY

Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

(2014) Daniel Ferreira et al.   Frontiers in Aging Neuroscience

The worldwide economic impact of dementia 2010

(2013) Anders Wimo et al.   Alzheimers & Dementia

Impaired Visual Recognition Memory Predicts Alzheimer's Disease in Amnestic Mild Cognitive Impairment

(2013) Mira Didic et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease

(2013) Christian Gaser et al.   PLoS One

Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review

(2013) Blossom Christa Maree Stephan et al.   BMJ Open

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

(2013) Xiao Da et al.   NeuroImage-Clinical

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

(2012) Heiko Braak et al.   CURRENT OPINION IN NEUROLOGY

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease

(2012) M. Wagner et al.   NEUROLOGY

Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction.

(2012) Eleni Aretouli et al.   NEUROPSYCHOLOGY

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study

(2012) Sebastian Palmqvist et al.   PLoS One

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Cognitive Decline in Prodromal Alzheimer Disease and Mild Cognitive Impairment

(2011) Robert S. Wilson et al.   ARCHIVES OF NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors

(2011) Yue Cui et al.   PLoS One

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

(2010) Michael Ewers et al.   NEUROBIOLOGY OF AGING

Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive Impairment

(2009) Amy J. Jak et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

CSF Biomarkers

(2009) Niklas Mattsson et al.   Annals of the New York Academy of Sciences

Longitudinal Study of the Transition From Healthy Aging to Alzheimer Disease

(2009) David K. Johnson et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe

(2009) J. Hort et al.   EUROPEAN JOURNAL OF NEUROLOGY

Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment

(2009) E. Dierckx et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm

(2009) Joanna Mitchell et al.   JOURNAL OF NEUROLOGY

Selectivity of executive function deficits in mild cognitive impairment.

(2009) Jason Brandt et al.   NEUROPSYCHOLOGY

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease

(2009) B. Schmand et al.   PSYCHOLOGICAL MEDICINE

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

(2009) N A Verwey et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms

(2008) Hélène Amieva et al.   ANNALS OF NEUROLOGY

Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

(2008) Davangere P. Devanand et al.   BIOLOGICAL PSYCHIATRY

Trajectory of mild cognitive impairment onset

(2008) DIANE B. HOWIESON et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease

(2008) ELLEN GROBER et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease

(2008) Mark W. Bondi et al.   NEUROPSYCHOLOGY REVIEW

Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

(2008) Breno S. O. Diniz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia